198 related articles for article (PubMed ID: 12186169)
1. The effects of cost-sharing on essential drug prescriptions, utilization of medical care and outcomes after acute myocardial infarction in elderly patients.
Pilote L; Beck C; Richard H; Eisenberg MJ
CMAJ; 2002 Aug; 167(3):246-52. PubMed ID: 12186169
[TBL] [Abstract][Full Text] [Related]
2. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
Liu SZ; Romeis JC
Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors.
Schneeweiss S; Walker AM; Glynn RJ; Maclure M; Dormuth C; Soumerai SB
N Engl J Med; 2002 Mar; 346(11):822-9. PubMed ID: 11893794
[TBL] [Abstract][Full Text] [Related]
4. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
Simpson E; Beck C; Richard H; Eisenberg MJ; Pilote L
Am Heart J; 2003 Mar; 145(3):438-44. PubMed ID: 12660666
[TBL] [Abstract][Full Text] [Related]
5. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000.
Pilote L; Beck CA; Karp I; Alter D; Austin P; Cox J; Humphries K; Jackevicius C; Richard H; Tu JV;
Can J Cardiol; 2004 Jan; 20(1):61-7. PubMed ID: 14968144
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
Austin PC; Tu JV; Ko DT; Alter DA
CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
[TBL] [Abstract][Full Text] [Related]
7. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
8. Changes in the treatment and outcomes of acute myocardial infarction in Quebec, 1988-1995.
Pilote L; Lavoie F; Ho V; Eisenberg MJ
CMAJ; 2000 Jul; 163(1):31-6. PubMed ID: 10920727
[TBL] [Abstract][Full Text] [Related]
9. Discharge prescriptions following admission for acute myocardial infarction at tertiary care and community hospitals in Quebec.
Beck CA; Lauzon C; Eisenberg MJ; Huynh T; Dion D; Roux R; Racine N; Carignan S; Diodati JG; Charbonneau F; Lévesque C; Pouliot J J; Pilote L L
Can J Cardiol; 2001 Jan; 17(1):33-40. PubMed ID: 11173312
[TBL] [Abstract][Full Text] [Related]
10. Regional variation in the management of acute myocardial infarction in the province of Quebec.
Rodrigues EJ; Simpson E; Richard H; Pilote L
Can J Cardiol; 2002 Oct; 18(10):1067-76. PubMed ID: 12420042
[TBL] [Abstract][Full Text] [Related]
11. Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction.
Austin PC; Tu JV; Ko DT; Alter DA
CMAJ; 2008 Oct; 179(9):895-900. PubMed ID: 18936454
[TBL] [Abstract][Full Text] [Related]
12. Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis.
Choudhry NK; Avorn J; Antman EM; Schneeweiss S; Shrank WH
Health Aff (Millwood); 2007; 26(1):186-94. PubMed ID: 17211028
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
Fernandes AW; Madhavan SS; Amonkar MM
Clin Ther; 2005 May; 27(5):630-45. PubMed ID: 15978313
[TBL] [Abstract][Full Text] [Related]
15. Reference-based pricing of prescription drugs: exploring the equivalence of angiotensin-converting-enzyme inhibitors.
Bourgault C; Elstein E; Le Lorier J; Suissa S
CMAJ; 1999 Aug; 161(3):255-60. PubMed ID: 10463046
[TBL] [Abstract][Full Text] [Related]
16. Impact of restrictive prescription plans on heart failure medication use.
Thanassoulis G; Karp I; Humphries K; Tu JV; Eisenberg MJ; Pilote L
Circ Cardiovasc Qual Outcomes; 2009 Sep; 2(5):484-90. PubMed ID: 20031881
[TBL] [Abstract][Full Text] [Related]
17. The impact of reducing cardiovascular medication copayments on health spending and resource utilization.
Choudhry NK; Fischer MA; Avorn JL; Lee JL; Schneeweiss S; Solomon DH; Berman C; Jan S; Lii J; Mahoney JJ; Shrank WH
J Am Coll Cardiol; 2012 Oct; 60(18):1817-24. PubMed ID: 23040581
[TBL] [Abstract][Full Text] [Related]
18. Adherence to statin therapy under drug cost sharing in patients with and without acute myocardial infarction: a population-based natural experiment.
Schneeweiss S; Patrick AR; Maclure M; Dormuth CR; Glynn RJ
Circulation; 2007 Apr; 115(16):2128-35. PubMed ID: 17420348
[TBL] [Abstract][Full Text] [Related]
19. Eliminating out-of-pocket drug costs may improve outcomes after myocardial infarction--but at what cost to Medicare?
Moran A; Goldman L
Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):606-7. PubMed ID: 18695697
[TBL] [Abstract][Full Text] [Related]
20. Hospital case volume and appropriate prescriptions at hospital discharge after acute myocardial infarction: a nationwide assessment.
Schiele F; Capuano F; Loirat P; Desplanques-Leperre A; Derumeaux G; Thebaut JF; Gardel C; Grenier C
Circ Cardiovasc Qual Outcomes; 2013 Jan; 6(1):50-7. PubMed ID: 23233747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
